Kawasaki disease: AHA statement and recommendations
Kawasaki Disease — NUEM Blog
Frontiers | Antibodies and Immunity During Kawasaki Disease
Kawasaki Disease Nursing Care Management: Study Guide
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Kawasaki disease incidence in children and adolescents: an observational study in primary care | British Journal of General Practice
![PDF] Treatment Options for Refractory Kawasaki Disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d8f3d0e9bcb78fb7089e50d6f77d0efc0737cd69/5-Figure1-1.png "PDF] Treatment Options for Refractory Kawasaki Disease | Semantic Scholar")
PDF] Treatment Options for Refractory Kawasaki Disease | Semantic Scholar
Kawasaki Disease – Pearls and Pitfalls – PaediatricFOAM
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
A retrospective cohort study of major adverse cardiac events in children affected by Kawasaki disease with coronary artery aneurysms in Thailand | PLOS ONE
Kawasaki Disease Nursing Care Management: Study Guide
A) Worldwide incidence of Kawasaki disease per 100,000 children... | Download Scientific Diagram
Lightning Learning: Kawasaki Disease — EM3
Kawasaki Disease May Increase the Risk of Subsequent Cerebrovascular Disease | Stroke
RACGP - Kawasaki disease – the importance of prompt recognition and early referral
Kawasaki Disease in Infants & Young Children - HealthyChildren.org
Kawasaki disease and coronary involvement – All About Cardiovascular System and Disorders
Kawasaki disease - Wikipedia
Treatment of Kawasaki disease | Download Table
Kawasaki Disease: Causes, Symptoms & Diagnosis
Kawasaki Disease: Complications and Treatment | American Heart Association
Mortality among Children with Kawasaki Disease in Japan | NEJM
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Kawasaki disease: AHA statement and recommendations
